orthopediatrics.com (KIDS): Debts to Book Capitalization

Brandmark of orthopediatrics.com (KIDS)

The production of pediatric orthopedic systems creates strong physician brand loyalty, as evidenced by the OrthoPediatrics Corp. (KIDS) stock quotes on GURU.Markets shown on this chart, where the indicator stands at 0.30. Its status as an exclusive player in the pediatric surgery segment allows the company to exercise significant pricing power. Business growth is driven by the systematic acquisition of promising patents and the integration of new startups into the core portfolio.

KIDS - OrthoPediatrics Debts to Net Assets over the range 07/04/2022 - 10/28/2026
Original product of orthopediatrics.com

Steady demand for pediatric orthopedic implants and clinic expansion require precise capital management to scale the business. An analysis of the total debt-to-equity ratio allows for an assessment of financial leverage, where an increasing coefficient accelerates asset development but heightens risks during cycle shifts, determining the overall stability of the financing structure of OrthoPediatrics Corp. (KIDS).

Competitors of OrthoPediatrics Corp.

BSX: Debts to Book Capitalization|Debts to Book Value edwards.com EW|RMD: Debts to Book Capitalization|PODD - Debt to Book Value|Zimmer Biomet - Debts to Book Capitalization|CooperSurgical (COO) - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization GMED|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio Alphatec Holdings (ATEC)|Debts to Book Capitalization AORT|ENOV - Debts to Net Assets|Debt to Book Value Integra LifeSciences|ESTA - Debts to Book Capitalization Ratio|Debts to Book Capitalization BBNX|IRADIMED Corp (IRMD) - Debts to Book Value|Debts to Book Capitalization Embecta Inc. (EMBC)|Debt to Book Value Ratio Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Debt to Book Value|Debt to Net Assets Ratio SIBN (si-bone.com)|Orthofix - Debt to Book Capitalization Ratio|Debt to Book Value Bioventus Inc BVS|TMCI (Treace Medical) - Debts to Book Capitalization|SRTA - Debts to Book Value|Debts to Book Capitalization Carlsmed Inc|rxsight.com (RXST) - Debt to Book Value Ratio|CLPT: Debts to Book Capitalization|Debts to Net Assets Stereotaxis Inc|Debts to Book Capitalization STIM (NeuroStar)|Debt to Book Value Sight Sciences Inc (SGHT)|Debts to Book Capitalization OBIO (Orchestra BioMed, Inc.)|Anika Therapeutics Inc. - Debts to Book Capitalization|NSPR - Debt to Book Capitalization Ratio|Jin Medical International (ZJYL) - Debt to Book Capitalization Ratio|Debt to Book Value vivani.com VANI|Xtant Medical (XTNT) - Debt to Net Assets Ratio|Debts to Book Capitalization NMTC (NeuroOne Medical Technologies)|Debts to Book Value MODD|MYO: Debt to Book Capitalization Ratio|Debt to Net Assets Envoy Medical Inc. COCH|Debt to Book Value VVOS (Vivos Therapeutics, Inc)|Debts to Book Capitalization enVVeno Corp NVNO|Debts to Book Capitalization SINT (SINTX Technologies)|TNON: Debts to Net Assets|Debt to Book Capitalization Ratio Lifeward (LFWD)|AMIX (Autonomix Medical) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio IVF|Debt to Book Value Bone Biologics Inc|Axonics, Inc. - Debts to Book Capitalization|Debts to Book Value BIOL (biolase.com)|DYNT - Debt to Book Capitalization Ratio|FNA - Debt to Book Value Ratio|Debt to Book Value INVO Bio INVO